Moxifloxacin-based triple therapy for helicobacter pylori eradication in type 2 diabetic patients / 中华全科医师杂志
Chinese Journal of General Practitioners
;
(6): 563-565, 2009.
Article
in Chinese
| WPRIM
| ID: wpr-393266
ABSTRACT
Alc in trial group were significant better than those in control group ( P < 0. 05 ). The results indicate that type 2 diabetic patients with Hp infection should receive moxifloxacin-based triple therapy as first-line treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of General Practitioners
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS